These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24853340)

  • 1. The role of bone morphogenetic proteins in myeloma cell survival.
    Holien T; Sundan A
    Cytokine Growth Factor Rev; 2014 Jun; 25(3):343-50. PubMed ID: 24853340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG-oligodeoxynucleotide inhibits Smad-dependent bone morphogenetic protein signaling: effects on myeloma cell apoptosis and in vitro osteoblastogenesis.
    Nørgaard NN; Holien T; Jönsson S; Hella H; Espevik T; Sundan A; Standal T
    J Immunol; 2010 Sep; 185(6):3131-9. PubMed ID: 20702733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells.
    Ro TB; Holt RU; Brenne AT; Hjorth-Hansen H; Waage A; Hjertner O; Sundan A; Borset M
    Oncogene; 2004 Apr; 23(17):3024-32. PubMed ID: 14691444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein (BMP)-2 induces apoptosis in human myeloma cells.
    Kawamura C; Kizaki M; Ikeda Y
    Leuk Lymphoma; 2002 Mar; 43(3):635-9. PubMed ID: 12002771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic proteins and receptors are over-expressed in bone-marrow cells of multiple myeloma patients and support myeloma cells by inducing ID genes.
    Grcević D; Kusec R; Kovacić N; Lukić A; Lukić IK; Ivcević S; Nemet D; Seiwerth RS; Ostojić SK; Croucher PI; Marusić A
    Leuk Res; 2010 Jun; 34(6):742-51. PubMed ID: 19926132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3.
    Kawamura C; Kizaki M; Yamato K; Uchida H; Fukuchi Y; Hattori Y; Koseki T; Nishihara T; Ikeda Y
    Blood; 2000 Sep; 96(6):2005-11. PubMed ID: 10979940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC.
    Holien T; Våtsveen TK; Hella H; Rampa C; Brede G; Grøseth LA; Rekvig M; Børset M; Standal T; Waage A; Sundan A
    Leukemia; 2012 May; 26(5):1073-80. PubMed ID: 21941367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma.
    Barillé S; Bataille R; Amiot M
    Eur Cytokine Netw; 2000 Dec; 11(4):546-51. PubMed ID: 11125296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical localization of bone morphogenetic proteins (BMPs) 2, 4, 6, and 7 during induced heterotopic bone formation.
    McCullough KA; Waits CA; Garimella R; Tague SE; Sipe JB; Anderson HC
    J Orthop Res; 2007 Apr; 25(4):465-72. PubMed ID: 17262821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of osteoblast suppression in multiple myeloma.
    Stewart JP; Shaughnessy JD
    J Cell Biochem; 2006 May; 98(1):1-13. PubMed ID: 16440324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease.
    Gooding S; Olechnowicz SWZ; Morris EV; Armitage AE; Arezes J; Frost J; Repapi E; Edwards JR; Ashley N; Waugh C; Gray N; Martinez-Hackert E; Lim PJ; Pasricha SR; Knowles H; Mead AJ; Ramasamy K; Drakesmith H; Edwards CM
    Nat Commun; 2019 Oct; 10(1):4533. PubMed ID: 31586071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.
    Ye L; Kynaston H; Jiang WG
    Mol Cancer Res; 2008 Oct; 6(10):1594-606. PubMed ID: 18922975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factors and antiapoptotic signaling pathways in multiple myeloma.
    van de Donk NW; Lokhorst HM; Bloem AC
    Leukemia; 2005 Dec; 19(12):2177-85. PubMed ID: 16239913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation.
    Boissy P; Andersen TL; Abdallah BM; Kassem M; Plesner T; Delaissé JM
    Cancer Res; 2005 Nov; 65(21):9943-52. PubMed ID: 16267019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Execution of BMP-4-induced apoptosis by p53-dependent ER dysfunction in myeloma and B-cell hybridoma cells.
    Fukuda N; Saitoh M; Kobayashi N; Miyazono K
    Oncogene; 2006 Jun; 25(25):3509-17. PubMed ID: 16449972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin.
    Abe E; Yamamoto M; Taguchi Y; Lecka-Czernik B; O'Brien CA; Economides AN; Stahl N; Jilka RL; Manolagas SC
    J Bone Miner Res; 2000 Apr; 15(4):663-73. PubMed ID: 10780858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.